Power Law company profile

ARS Pharmaceuticals

Biotech & Life Sciences · San Diego, United States · Founded 2015 Unicorn

ARS Pharmaceuticals is a stealth pharmaceutical company

Valuation

$500M–1B

Latest valuation · May/2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

3 investors on ARS Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 3 investors entered at this stage

Deerfield

SR One

RA Capital Management

Global footprint

Where ARS Pharmaceuticals has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States99.1%

🇬🇭 Ghana0.9%

2 countries shown

Web traffic by country

20K monthly visits
across markets

🇺🇸 United States61.5%

🇮🇳 India15.5%

🇨🇦 Canada8%

🇬🇧 United Kingdom7.5%

🇵🇭 Philippines5.5%

Top 5 markets shown

Patent intelligence

$7M patent portfolio · 5 active families

Estimated portfolio value

$7M

0.99% of valuation · 41.6× smaller than top peer argenx ($275M)

5 active patent families

Where ARS Pharmaceuticals innovates Molecular biologyCancer researchAntiendomysial antibodiesPharmaceutical drugAntibody conjugate

Where ARS Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across ARS Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about ARS Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about ARS Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ARS Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles